Search research articles
Contact Us
Filters
Showing results (21-30 of 251) with videos related to
Page
of 26
Sort By:
European Urology
|
March 27, 2024
Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7
Christopher J Logothetis, Andrew W Hahn
European Urology
|
May 20, 2023
Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome
Christopher J Logothetis, Andrew W Hahn
European Urology
|
October 23, 2010
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
Christopher J Logothetis, Arlene Siefker-Radtke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Informative clinical investigation: a demanding taskmaster
Eleni Efstathiou, Jeri Kim, Christopher J Logothetis
Cancer Genomics & Proteomics
|
May 18, 2012
In silico functional profiling of individual prostate cancer tumors: many genes, few functions
Ivan P Gorlov, Jinyoung Byun, Christopher J Logothetis
International Journal of Cancer
|
June 25, 2009
Housekeeping genes in prostate tumorigenesis
Jinyoung Byun, Christopher J Logothetis, Ivan P Gorlov
Cancer Discovery
|
May 16, 2012
Understanding the lethal variant of prostate cancer: power of examining extremes
Ana Aparicio, Christopher J Logothetis, Sankar N Maity
Seminars in Oncology
|
June 4, 2004
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer
Paul Mathew, Isaiah J Fidler, Christopher J Logothetis
The Lancet. Oncology
|
July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumours
Shi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Understanding the biology of bone metastases: key to the effective treatment of prostate cancer
Christopher J Logothetis, Nora M Navone, Sue-Hwa Lin
Page
of 26
Search research articles
Search
Showing results (21-30 of 251) with videos related to
Sort By:
Page
of 26
European Urology
|
March 27, 2024
Reply to Richard J. Wassersug, Paul F. Schellhammer, and Erik Wibowo's Letter to the Editor re: Christoper J. Logothetis, Andrew W. Hahn. Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome. Eur Urol 2024;85:3-7
Christopher J Logothetis, Andrew W Hahn
European Urology
|
May 20, 2023
Challenging the Prevailing Therapeutic Dogma for Prostate Cancer: The Case for an Overlap Syndrome
Christopher J Logothetis, Andrew W Hahn
European Urology
|
October 23, 2010
Words of wisdom. Re: final results of sequential doxorubicin plus gemcitabine and ifosfamide, paclitaxel, and cisplatin chemotherapy in patients with metastatic or locally advanced transitional cell carcinoma of the urothelium
Christopher J Logothetis, Arlene Siefker-Radtke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2009
Informative clinical investigation: a demanding taskmaster
Eleni Efstathiou, Jeri Kim, Christopher J Logothetis
Cancer Genomics & Proteomics
|
May 18, 2012
In silico functional profiling of individual prostate cancer tumors: many genes, few functions
Ivan P Gorlov, Jinyoung Byun, Christopher J Logothetis
International Journal of Cancer
|
June 25, 2009
Housekeeping genes in prostate tumorigenesis
Jinyoung Byun, Christopher J Logothetis, Ivan P Gorlov
Cancer Discovery
|
May 16, 2012
Understanding the lethal variant of prostate cancer: power of examining extremes
Ana Aparicio, Christopher J Logothetis, Sankar N Maity
Seminars in Oncology
|
June 4, 2004
Combination docetaxel and platelet-derived growth factor receptor inhibition with imatinib mesylate in prostate cancer
Paul Mathew, Isaiah J Fidler, Christopher J Logothetis
The Lancet. Oncology
|
July 31, 2002
Stem-cell origin of metastasis and heterogeneity in solid tumours
Shi-Ming Tu, Sue-Hwa Lin, Christopher J Logothetis
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2008
Understanding the biology of bone metastases: key to the effective treatment of prostate cancer
Christopher J Logothetis, Nora M Navone, Sue-Hwa Lin
Page
of 26